Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178594 · ClinicalTrials.gov registry record
Evaluation of Hemostasis in Bleeding and Thrombotic Disorders
A clinical trial of Blood Coagulation Disorders, Inherited and Thrombotic Disorder, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT00178594: Recruiting study of Blood Coagulation Disorders, Inherited and Thrombotic Disorder, sponsored by The University of Texas Health Science Center, Houston.
NCT00178594 is a study of Blood Coagulation Disorders, Inherited and Thrombotic Disorder that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,000 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00178594, a study of Blood Coagulation Disorders, Inherited and Thrombotic Disorder, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.
Conditions Studied
Study Locations (2)
Texas
- The Univerisity of Texas Health Science Center at Houston - Houston
- UT Physicians Women's Center-Texas Medical Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2002-10 |
| Est. Completion | 2028-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178594
The ClinicalTrials.gov registry entry for NCT00178594 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Blood Coagulation Disorders, Inherited appearing as the primary indexed condition, and to 0 interventions.
NCT00178594 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00178594 about?
NCT00178594 is a clinical study titled "Evaluation of Hemostasis in Bleeding and Thrombotic Disorders". The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.
What is the current status of trial NCT00178594?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2002-10. Estimated completion is 2028-01.
What conditions does trial NCT00178594 study?
This clinical trial studies the following conditions: Blood Coagulation Disorders, Inherited, Thrombotic Disorder.
Who is sponsoring clinical trial NCT00178594?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00178594 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Coagulation Disorders, Inherited
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.